期刊文献+

1H-吲唑类中间体的合成及表征 被引量:1

Synthesis and Characterization of Novel 1H-Indazole Derivatives
下载PDF
导出
摘要 以取代邻甲苯胺为原料经乙酰化、溴化、环合及胺解反应得到1H-吲唑类化合物,再与酸酐、碘乙烷或硝酸反应以较高收率合成了15个1H-吲唑衍生物,其中12个未见文献报道。其结构经1H NMR、IR表征确认。 Fifteen 1H-indazole derivatives were prepared in several steps starting from substituted o-toluidine,among which twelve compounds were firstly reported herein. The structures of the products were characterized by1H NMR and IR spectra.
出处 《精细化工中间体》 CAS 2013年第5期19-22,共4页 Fine Chemical Intermediates
基金 国家"十二五"科技支撑计划项目(2012BAK25B03)
关键词 1H-吲唑 中间体 合成 1H-indazole intermediates synthesis
  • 相关文献

参考文献11

  • 1Carla M C, Chad C E, Brenda C W. A praetical, metal-free synthesis of 1H-indazoles [J]. Organic Letters, 2008, 10 (5) : 1 021-1 023.
  • 2Borchardt A J. Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use: US, 0124662[PJ. 2005-06-09.
  • 3Chen H S, Huang L J, Shih M L, et al. Synthesis of N2- (substituted benzyl)-3-(4-methylphenyl)indazoles as novel anti- angiogenio agents [J]. Bioorganic and Medicinal Chemistry, 2006, 14 (2): 528-536.
  • 4侯长军,罗斌,霍丹群.氯尼达明合成路线的研究[J].药学进展,2006,30(5):235-237. 被引量:7
  • 5施和平,陈亮.新型植物生长调节剂1-甲基-3-氧乙酸吲唑的合成和应用[J].应用化学,2000,17(4):420-421. 被引量:2
  • 6易奋飞.1H-吲唑类化合物的合成方法改进及IGF-IR抑制剂的合成[D].西南石油大学,2011.
  • 7王永珍,赵砚瑾,李庶心.盐酸帕唑帕尼的合成工艺改进[J].精细化工中间体,2013,43(2):46-48. 被引量:3
  • 8易奋飞,何毅.两种吲唑合成方法的改进[J].化学通报,2011,74(8):760-764. 被引量:3
  • 9Creeyst F, Lohou E, Stiebing S, et al. Protected indazole boronic acid pinacolyl esters : facile syntheses and studies of reactivities in suzuki-mlyanra cross-couphng and hydroxydeboronation reactions [J].Synlett, 2009, 4: 615-619.
  • 10Antonello M, Chiara O, Tecla G, et al. The Suzuki reaction applied to the synthesis of novel pyrrolyl and thiophenyl indazoles [J]. Molecules, 2012, 17:4 508-4 521.

二级参考文献31

  • 1张万年,吕加国,朱驹,徐卫明.氯尼达明的合成[J].中国医药工业杂志,1995,26(3):103-104. 被引量:4
  • 2Horning E C 南京大学化学系有机化学教研组(译).有机合成(第1版,第3集)[M].北京:科学出版社,1981.292.
  • 3Kyowa Hakko Kogyo CO. , Ltd. Tokyo : EP1847532 A 1,2005.
  • 4I Candiani, G D' Arasmo, F Heidempergher et a|. Org. Proc. Res. Deve. ,2009,13 (3) :456 - 462.
  • 5K Lukin,M C Hsu, D Fernando et al. J. Org. Chem. ,2006,71 (21) :8166 - 8172.
  • 6X M Li,S Chu,V A Feher et al. J. Med. Chem. ,2003,46(26) :5663 -5673.
  • 7K Inamoto,M Katsuno,T Yoshino et al. Tetrahedron,2007,63(12) :2695 -2711.
  • 8D D Gaikwad,S Abedl ,R P Pawar et al. Int. J. Chem. Tech. Res. ,2009,1 (3) :442 -445.
  • 9J J Cui,G-L Araldi,J E Reiner et al. Bioorg. Med. Chem. Lett. ,2002,12(20) :2925 -2930.
  • 10P Schumann,V Collot,Y Hommet et al. Bioorg. Med. Chem. Lett. ,2001,11 (9) :1153 - 1156.

共引文献11

同被引文献9

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部